Immunomodulating therapy by picibanil-based imiquimod and virotherapy for advanced uterine cancer after laparoscopic surgery

Medicine and Dentistry

• Abdominal Tumor 20%
• Adenocarcinoma 20%
• Adjuvant Chemotherapy 20%
• Cancer Surgery 20%
• Carboplatin 40%
• Case Report 20%
• CD8 Antigen 20%
• Chemoradiotherapy 20%
• Chemotherapy 20%
• Colon 20%
• Combination Therapy 100%
• Cytotechnology 20%
• Diaphragm 20%
• Doxorubicin 40%
• Endometrioid Carcinoma 20%
• Flank 20%
• Gynecology 20%
• Hyperthermic Intraperitoneal Chemotherapy 40%
• Hysterectomy 20%
• Imiquimod 100%
• Immunotherapy 100%
• Interleukin 2 40%
• Laparoscopic Surgery 100%
• Liver 40%
• Lung 20%
• Lymph Node 20%
• Malignant Neoplasm 20%
• Myometrium 20%
• Neoplasm 20%
• Obstetrics 20%
• Omentum 20%
• Paclitaxel 60%
• Paraaortic Lymph Node 20%
• Pathology 20%
• Patient 100%
• Pelvis 60%
• Peritoneum 20%
• Picibanil 100%
• Positron Emission Tomography 20%
• Rectum 20%
• Rectum Resection 20%
• Retroperitoneal Lymph Node Dissection 40%
• Robot-Assisted Surgery 20%
• Salpingooophorectomy 20%
• Surgery 60%
• Surgical Anastomosis 20%
• T Cell Proliferation 20%
• Tumor Recurrence 20%
• Uterine Cancer 100%
• Vagina Bleeding 20%
• Virotherapy 100%
• Wart Virus Vaccine 20%
• Washing 20%